Summaries the main effect of globalization and discuss to what extent they are beneficial to your subject area.

GLOBALISATION, a term that was used infrequently before the 1990s, is now common manner of speaking. It refers primarily to an economic system in which raw materials, manufactured goods, intellectual property and financial transactions flow freely although not equally across international borders under the supervision only of an international trade authority (Ehrenfeld D, 2003). It also refers to the homogenization of language and cultural identity that accompanies this change of material, ideas and money.
This present wave of globalization has been motivated by policies that have opened economies domestically and internationally. After the Second World War, and especially during the past two decades, many governments have adopted free-market economic systems, enormously increasing their own productive potential and creating numerous new opportunities for international trade and investment. They also have negotiated remarkable reductions in barriers to commerce and have established international agreements to promote trade in goods, services, and investment. Corporations have built foreign factories and established production and marketing arrangements with foreign partners by taking benefit of new opportunities in foreign markets. ( Endowment c, 2003).
Rapid progression of science and technology in the 21st century largely changed the industrial structure, society and the way of life and brought significant benefits such as overcome of many diseases and prolongation of life-span. The pharmaceutical industry has taken advantage of the modern trend of globalisation to increase their assets and power in medical healthcare across the globe. Companies spend large amounts of money on advertising, marketing and lobbying. The industry spends roughly US$19 billion a year for that sole cause. In some countries, such as the United States of America, companies are allowed to promote their firms or products directly to the public. Consequently, this has allowed some companies to specialize in data and analytics for pharmaceutical marketing (Ministry of health, labor and welfare, 2007).
Globalization shows its impact on Indian Pharmaceutical Industry that it brought in huge amounts of foreign currency into the industry which in its turn helped to boost the Indian economy. As many transnational pharmaceutical companies are now linked with the Indian Pharmaceutical Industry it increased the number of jobs that were available to the people of this country. Foreign pharmaceutical companies also brought in highly advanced technology into the Indian Pharmaceutical industries and this improved the quality of medicines that were available to the native people. Many Indian pharmaceutical companies took over international pharmaceutical companies such as Ranbaxy merged with Croslands, Wockhardt with Merind7, and Nicholas Piramal with Sumitra Pharma. This helped the Indian pharmaceutical companies to grow and make even more profits (Globalisation of Indian Pharmaceutical Industry).
Clinical research is now considered as one of the promising and fastest growing area in the Pharmaceutical industry. According to the Lead Discovery reports, the global clinical trials industry is currently about $10 billion and has the potential for fast growth in the future. The Indian clinical trial market has grown from $35 million in 2002 to $120 million in 2006. It was estimated that this market will grow to a large extent by 2010. Centre Watch expects it to be around US$ 250-300 million1, whereas McKinsey estimates a much higher figure of US$ 1.0-1.5 billion2. In 2002 40-50 clinical trials were conducted by 200-250 investigators and presently we have 700-1000 investigators in India. In USA 40000 investigators are conducting about 60000 trials (Dr.Mandal S C, 2008). In medicines research cooperation of transnational industries would also have great economic advantages for rising two-way trade by reducing development costs of drugs in both countries. It would represent a most important opportunity for ensuring that the expenditure of public monies in this area is restricted to products offering proven profit to the community in terms of both costs and comparative effectiveness. For example, in order to achieve this mutually beneficial end a China-Australia create the opportunity for ongoing exchange of ideas between the drug regulatory and pricing authorities of both countries to ensure suitable regulatory harmonization, compatibility and transparency (Faunce T A,2005).
Global pharmaceutical communities decided to come together in their efforts to deal with globalisation of infectious diseases. Under the control of the United Nations and its agencies, such as UNAIDS, WHO, UNICEF and UN-Habitat, 191 member countries of the United Nations pledged to attain eight Millennium Development Goals (MDGs) by 2015. It have Five goals are in the health area; they are reducing child death, reversing the spread of HIV/AIDS, improving maternal health, and malaria, and ensuring sustainable environmental health. They also tackle with those determinants of health such as reducing the proportion of people without sustainable safe drinking water, and improving the lives of at least 100 million slum dwellers.(Dr.Shisana O,2005) To ensure that these goals are implemented, the member states pledged to establish a global partnership for development with the objective of developing further “an open trading and financial system that is rule-based, predictable and non-discriminatory” that includes a “commitment to good governance, development and poverty reduction -nationally and internationally” (UN Millennium Development Goals).
The above essay concludes that Globalisation is very common now a day’s and it affects on various areas, which includes business, culture, language, ideas and services. Pharmaceutical companies have achieved great success because of Globalisation; this has increased their profit and power in medical healthcare all over the world. The link between transnational companies with many developing and developed countries like India, China, Australia and America has resulted in increase in their economy. The above figures of clinical research prove that it is one of the fast growing areas of pharmaceutical sciences. Global pharmaceutical communities have come together in order to tackle with various infectious diseases and has helped in increasing the standard of living. After studying the impacts of Globalisation in the field of pharmaceutical sciences I strongly believe that it will surely bring development in this field through new researches and inventions.

.jpg)